Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Angle Share News (AGL)
AGL Share
Price
AGL Share
News
AGL Share
Chat
AGL Share
Trades37
AGL
Live RNS
AGL Share
Charts
AGL Broker
Ratings
AGL Directors
Deals
AGL Financial
Diary
AGL
Fundamentals
AGL Short
Positions
AGL
Media
AGL Company
Research
AGL Company
Timeline
- There is currently no data for AGL
IN BRIEF: Angle highlights supportive data for DNA analysis tool
Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.
Current stock price: 17.85 pence, down 8.5% in London on Monday
12-month change: down 42%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Latest AGL News
- AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook
24 Apr 2024 - IN BRIEF: Angle granted patents in US and Europe for Cellkeep slide
22 Apr 2024 - Angle granted European patent for CellKeep, US patent imminent
22 Apr 2024 - LONDON MARKET CLOSE: Stocks up ahead of US nonfarm payrolls
4 Jan 2024 - Angle shares soar following "breakthrough" cancer diagnostics results
4 Jan 2024 - LONDON MARKET MIDDAY: Retailers Next and JD Sports bookend FTSE 100
4 Jan 2024 - AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up
4 Jan 2024
Related News
IN BRIEF: Angle names Peter Collins as interim CEO
(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...
Angle touts planned name and strategy change, Groen turns executive
(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...
IN BRIEF: Angle CEO and finance lead step down after shareholder talks
Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...
Angle News
AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
IN BRIEF: Angle granted patents in US and Europe for Cellkeep slide
Angle PLC - Surrey-based medical diagnostics provider - Says it has been granted a European and US patent for its CellKeep slide. "We are delighted to...
Angle granted European patent for CellKeep, US patent imminent
(Sharecast News) - Liquid biopsy specialist Angle announced on Monday that it has received a European patent for its 'CellKeep' slide, as it anticipat...
IN BRIEF: Angle highlights supportive data for DNA analysis tool
Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Is...
LONDON MARKET CLOSE: Stocks up ahead of US nonfarm payrolls
(Alliance News) - Stock prices in London closed higher on Thursday, as investors eye the latest US non-farms data.
Angle shares soar following "breakthrough" cancer diagnostics results
(Alliance News) - Angle PLC on Thursday said that "breakthrough results" from its latest blood sample cancer trials would allow it to expand its produ...
LONDON MARKET MIDDAY: Retailers Next and JD Sports bookend FTSE 100
(Alliance News) - Stock prices in London were slightly higher at midday on Thursday, with the FTSE 100 looking set to snap the two-day losing streak i...
AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.
Follow the stocks
